Safety of <scp>mRNA COVID</scp> ‐19 vaccines in patients with well‐controlled myasthenia gravis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Safety of mRNA COVID ‐19 vaccines in patients with well‐controlled myasthenia gravis

Published:2022-08-27 Issue:5 Volume:66 Page:612-617
ISSN:0148-639X
Container-title:Muscle & Nerve
language:en
Short-container-title:Muscle and Nerve

Author:

Gamez Josep¹^ORCID,Gamez Alejandro²,Carmona Francesc³

Affiliation:

1. Neurology Department, GMA Clinic, European Reference Network on Rare Neuromuscular Diseases Autonomous University of Barcelona Barcelona Spain

2. Neurophtalmology Department Hospital San Rafael Barcelona Spain

3. Department of Genetics, Microbiology and Statistics University of Barcelona Barcelona Spain

Publisher

Wiley

Subject

Physiology (medical),Cellular and Molecular Neuroscience,Neurology (clinical),Physiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/mus.27703

Reference38 articles.

1. Myasthenia Gravis and COVID-19: Clinical Characteristics and Outcomes

2. Immunosuppression in chronic autoimmune neurological disorders during the COVID-19 pandemic

3. COVID-19-associated risks and effects in myasthenia gravis (CARE-MG)

4. ANA Investigates: Neurological Complications of COVID ‐19 Vaccines

5. Helping the Public Understand Adverse Events Associated With COVID-19 Vaccinations

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Patient‐reported daily functioning after SARS‐CoV‐2 vaccinations in autoimmune neuromuscular diseases;European Journal of Neurology;2024-09-05

2. COVID-19 in patients with myasthenia gravis: a single-center retrospective study in China;Neurological Sciences;2024-04-23

3. Safety of SARS-CoV-2 vaccine in patients with autoimmune neurological conditions: A systematic review and meta-analysis;Heliyon;2024-01

4. Safety and neutralization antibody levels of inactivated SARS-CoV-2 vaccine in adult patients with Myasthenia Gravis: a prospective observational cohort study;Neurological Sciences;2023-11-09

5. Safety of SARS-CoV-2 vaccines in patients with myasthenia gravis: a meta-analysis;Neurological Sciences;2023-05-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3